The search for a preventive and therapeutic vaccine for HIV has long been studied. A look at past and current research shows just how far we’ve come.
Scientists are working on a variety of molecular and imaging diagnostics to advance the early detection rate of cancer.
A behind-the-scenes look at what goes into a successful flu immunization clinic, whether it’s large or small.
New options in immune globulin therapy give patients more options for receiving this gold-standard treatment.
Providers hoping to counteract the anti-vaccine movement can cultivate trust by setting aside time for vaccine discussions and using effective, empathetic communication to encourage vaccine compliance.
Rabies is a viral infection that is easily preventable, but almost always fatal if not treated.
A look at the extraordinary safety record of the plasma industry's continuous supply of safe therapies at volume.
During the past three decades,IVIG has proven an effective treatment for a wide range of autoimmune diseases, and it is now believed that IVIG may have clinical uses for a broader range of medical conditions.
The current H1N1 pandemic exemplifies the need for more expeditious production of flu vaccine, and two companies have placed this technology just within reach.
Scientists around the world are working to improve upon and create new therapeutic options for hemophiliacs.
With the FDA approval of SCIG therapy in 2006, many patients now have the choice between SCIG and IVIG infusions. Understanding the differences between the two treatment modalities will help healthcare providers recommend the right one for their patients.
